Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tDCS for Cancer Related Fatigue
NCT07159100Phase 1Not yet recruiting
- Sponsor
- Kessler Foundation
- Start
- Sep 2025
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cancer-related fatigue (CRF) and muscle weakness (2 arms), sponsored by Kessler Foundation. Primary endpoints: Fatigue task duration and Muscle Strength. Planned start Sep 2025; status: not yet recruiting.
02
Conditions
cancer-related fatigue (CRF)muscle weakness
Beyond the preview
Go deeper on NCT07159100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07159100.